Login / Signup
Carl Walkey
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Open Label
Long Non Coding Rna
Combination Therapy
Regulatory T Cells
Top Venues
Molecular cancer therapeutics
Cancer immunology research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Christie-Lynn Mortales
,
Benjamin Dutzar
,
Jerry Chen
,
Alex C Chen
,
Justin Huard
,
Carl Walkey
,
Ryan Swanson
NL-201 upregulates MHC-I expression and intratumoral TCR diversity, and demonstrates robust antitumor activity as monotherapy and in combination with PD-1 blockade.
Cancer immunology research
(2023)
Xuefeng Li
,
Kristin M Huntoon
,
Yifan Wang
,
DaeYong Lee
,
Shiyan Dong
,
Abin Antony
,
Carl Walkey
,
Yon Son Betty Kim
,
Wen Jiang
Radiation Synergizes with IL-2/IL-15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity.
Molecular cancer therapeutics
(2023)